Teva Pharmaceutical Industries Ltd (TEVA) - Total Liabilities

Latest as of December 2025: ILA32.84 Billion ILA ≈ $88.04 Million USD

Based on the latest financial reports, Teva Pharmaceutical Industries Ltd (TEVA) has total liabilities worth ILA32.84 Billion ILA (≈ $88.04 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TEVA cash flow conversion to assess how effectively this company generates cash.

Teva Pharmaceutical Industries Ltd - Total Liabilities Trend (1985–2025)

This chart illustrates how Teva Pharmaceutical Industries Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Teva Pharmaceutical Industries Ltd to evaluate the company's liquid asset resilience ratio.

Teva Pharmaceutical Industries Ltd Competitors by Total Liabilities

The table below lists competitors of Teva Pharmaceutical Industries Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Tiangong International Company Limited F:34T1	Germany	€5.96 Billion
OceanFirst Financial Corp NASDAQ:OCFC	USA	$12.90 Billion
Generation Development Group Ltd AU:GDG	Australia	AU$5.58 Billion
Mirae Asset Venture Investment Co. Ltd KQ:100790	Korea	₩721.23 Billion
Sivers IMA Holding AB ST:SIVE	Sweden	Skr374.60 Million
Guizhou Gas Group Corporation Ltd Class A SHG:600903	China	CN¥7.33 Billion
Hangzhou Sunrise Technology Co Ltd SHE:300360	China	CN¥719.08 Million
Ningbo Dechang Electrical Machinery Made Co Ltd SHG:605555	China	CN¥2.22 Billion

Liability Composition Analysis (1985–2025)

This chart breaks down Teva Pharmaceutical Industries Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Teva Pharmaceutical Industries Ltd (TEVA) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.81	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Teva Pharmaceutical Industries Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Teva Pharmaceutical Industries Ltd (1985–2025)

The table below shows the annual total liabilities of Teva Pharmaceutical Industries Ltd from 1985 to 2025.

Year	Total Liabilities	Change
2025-12-31	ILA32.84 Billion ≈ $88.05 Million	-2.28%
2024-12-31	ILA33.61 Billion ≈ $90.10 Million	-4.94%
2023-12-31	ILA35.35 Billion ≈ $94.78 Million	+0.11%
2022-12-31	ILA35.31 Billion ≈ $94.68 Million	-3.04%
2021-12-31	ILA36.42 Billion ≈ $97.65 Million	-7.98%
2020-12-31	ILA39.58 Billion ≈ $106.11 Million	-6.67%
2019-12-31	ILA42.41 Billion ≈ $113.69 Million	-5.53%
2018-12-31	ILA44.89 Billion ≈ $120.35 Million	-13.46%
2017-12-31	ILA51.87 Billion ≈ $139.06 Million	-10.41%
2016-12-31	ILA57.90 Billion ≈ $155.22 Million	+137.96%
2015-12-31	ILA24.33 Billion ≈ $65.23 Million	+5.49%
2014-12-31	ILA23.07 Billion ≈ $61.84 Million	-7.27%
2013-12-31	ILA24.87 Billion ≈ $66.68 Million	-10.35%
2012-12-31	ILA27.74 Billion ≈ $74.38 Million	-0.21%
2011-12-31	ILA27.80 Billion ≈ $74.53 Million	+63.04%
2010-12-31	ILA17.05 Billion ≈ $45.71 Million	+17.17%
2009-12-31	ILA14.55 Billion ≈ $39.01 Million	-12.05%
2008-12-31	ILA16.54 Billion ≈ $44.35 Million	+71.40%
2007-12-31	ILA9.65 Billion ≈ $25.88 Million	+3.85%
2006-12-31	ILA9.29 Billion ≈ $24.92 Million	+114.29%
2005-12-31	ILA4.34 Billion ≈ $11.63 Million	+2.48%
2004-12-31	ILA4.23 Billion ≈ $11.35 Million	+61.55%
2003-12-31	ILA2.62 Billion ≈ $7.02 Million	-6.18%
2002-12-31	ILA2.79 Billion ≈ $7.49 Million	+34.43%
2001-12-31	ILA2.08 Billion ≈ $5.57 Million	+22.01%
2000-12-31	ILA1.70 Billion ≈ $4.56 Million	+75.22%
1999-12-31	ILA971.72 Million ≈ $2.61 Million	+25.16%
1998-12-31	ILA776.40 Million ≈ $2.08 Million	+34.89%
1997-12-31	ILA575.60 Million ≈ $1.54 Million	-18.49%
1996-12-31	ILA706.20 Million ≈ $1.89 Million	+52.30%
1995-12-31	ILA463.70 Million ≈ $1.24 Million	+39.00%
1994-12-31	ILA333.60 Million ≈ $894.37K	+13.08%
1993-12-31	ILA295.00 Million ≈ $790.88K	+32.94%
1992-12-31	ILA221.90 Million ≈ $594.91K	+14.56%
1991-12-31	ILA193.70 Million ≈ $519.30K	-6.96%
1990-12-31	ILA208.20 Million ≈ $558.18K	+24.45%
1989-12-31	ILA167.30 Million ≈ $448.53K	+12.28%
1988-12-31	ILA149.00 Million ≈ $399.46K	+75.29%
1986-12-31	ILA85.00 Million ≈ $227.88K	-4.71%
1985-12-31	ILA89.20 Million ≈ $239.14K	--

About Teva Pharmaceutical Industries Ltd

TA:TEVA Israel Drug Manufacturers - Specialty & Generic

Market Cap

$32.40 Billion

ILA12.09 Trillion ILA

Market Cap Rank

#8743 Global

#86 in Israel

Share Price

ILA10380.00

Change (1 day)

+0.97%

52-Week Range

ILA5374.00 - ILA11350.00

All Time High

ILA25447.60